MECP2 and associated Rett syndrome (WP3584)

Homo sapiens

Open in new tab Open in NDEx Open in Newt (SBGN)
Download PNG Download SVG Download JSON Download GPML Learn more about Downloads
MECP2 (methyl-CpG binding protein 2) is in many mammals an important regulator of neuronal function and development. It affects all cell types, especially neurons but also astrocytes, oligodendrocytes, and glial cells. MECP2 plays an important role in neuronal differentiation, maturation, morphology and function and influences synaptic plasticity. Mutations impairing the proper function of MECP2 are mainly associated with the Rett syndrome but may also contribute to other neurological disorders like schizophrenia, FASD (fetal alcohol syndrome), PPM-X-syndrome, autism, Prader-Will-syndrome, and Angelman-syndrome. Dependant on the cofactors MECP2 acts as an activator or repressor of transcription and micro RNA production. It affects RNA splicing and regulates chromatin structure together with HP1 and interferes in methylation of DNA (epigenetics). The expression of MECP2 itself is highly regulated by promotor elements, cis-regulatory elements, polyadenylation, promotor DNA methylation and miRNA. Please cite this pathways as: http://www.wikipathways.org/instance/WP3584 Ehrhart et al. 2016 https://doi.org/10.1186/s13023-016-0545-5 - the pathway version in the paper is 90609. Proteins on this pathway have targeted assays available via the [https://assays.cancer.gov/available_assays?wp_id=WP3584 CPTAC Assay Portal]

Authors

Friederike Ehrhart , Egon Willighagen , Kristina Hanspers , Ryan Miller , Martina Summer-Kutmon , Alex Pico , Lauren J. Dupuis , and Eric Weitz

Activity

last edited

Discuss this pathway

Check for ongoing discussions or start your own.

Cited In

Are you planning to include this pathway in your next publication? See How to Cite and add a link here to your paper once it's online.

Organisms

Homo sapiens

Communities

Diseases Rare Diseases

Annotations

Disease Ontology

Rett syndrome

Pathway Ontology

disease pathway

Cell Type Ontology

oligodendrocyte microglial cell astrocyte

Participants
Query Drugst.One

Label Type Compact URI Comment
Dopamine Metabolite hmdb:HMDB0000073
GABA Metabolite chebi:16865
Glycine Metabolite hmdb:HMDB0000123
Norepinephrine Metabolite hmdb:HMDB0000216
NMDA Metabolite hmdb:HMDB0002393 N-Methyl-D-aspartic acid
Glutamate Metabolite chebi:29987
Serotonin Metabolite hmdb:HMDB0000259
Trofinetide Metabolite pubchem.compound:11318905
Melatonin Metabolite hmdb:HMDB0001389
Myoinositol Metabolite hmdb:HMDB0000211
D-serine Metabolite chebi:16523
NCOR1 GeneProduct ensembl:ENSG00000141027 nuclear receptor co-repressor 1
MYT1 GeneProduct ensembl:ENSG00000196132 myelin transcription factor 1
proof of Mecp2 inhibition in Oligodendrocytes
BRN3 GeneProduct ensembl:ENSG00000152192 POU domain, class 4, transcription factor 1
DLX5 GeneProduct ensembl:ENSG00000105880
MTOR GeneProduct ensembl:ENSG00000198793
APOC2 GeneProduct ensembl:ENSG00000234906 apolipoprotein C-II
HDAC1 GeneProduct ensembl:ENSG00000116478
BDNF GeneProduct ensembl:ENSG00000176697 brain derived neurotrophic factor
SST GeneProduct ensembl:ENSG00000157005 Somatostatin
NREP GeneProduct ensembl:ENSG00000134986 neuronal regeneration related protein
TET3 GeneProduct ensembl:ENSG00000187605
MECP2 GeneProduct ensembl:ENSG00000169057 methyl CpG binding protein 2
BRN2 GeneProduct ensembl:ENSG00000184486 POU domain, class 3, transcription factor 2
DLX6 GeneProduct ensembl:ENSG00000006377
SMC3 GeneProduct ensembl:ENSG00000108055 tructural maintenance of chromosomes 3
MEF2C GeneProduct ensembl:ENSG00000081189 myocyte enhancer factor 2C
TAP1 GeneProduct ensembl:ENSG00000168394 transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)
UBE3A GeneProduct ensembl:ENSG00000114062
RBFOX1 GeneProduct ensembl:ENSG00000078328 ataxin 2 binding protein 1, Rbfox1
CNP GeneProduct ensembl:ENSG00000173786 2',3'-cyclic nucleotide 3' phosphodiesterase
TET2 GeneProduct ensembl:ENSG00000168769
SGK1 GeneProduct ensembl:ENSG00000118515
FKBP5 GeneProduct ensembl:ENSG00000096060
RPS6 GeneProduct ensembl:ENSG00000137154
EZH2 GeneProduct ensembl:ENSG00000106462 histone H3 lysine 27 methyltransferase
GAMT GeneProduct ensembl:ENSG00000130005 guanidinoacetate methyltransferase
AKT1 GeneProduct ensembl:ENSG00000142208
MPP1 GeneProduct ensembl:ENSG00000130830
OPRK1 GeneProduct ensembl:ENSG00000082556 opioid receptor, kappa 1
ARHGEF26 GeneProduct ensembl:ENSG00000114790 Rho guanine nucleotide exchange factor (GEF) 26
SIN3A GeneProduct ensembl:ENSG00000169375
IGF2 GeneProduct ensembl:ENSG00000167244
SP1 GeneProduct ensembl:ENSG00000185591 trans-acting transcription factor 1
GAD1 GeneProduct ensembl:ENSG00000128683
TAF1 GeneProduct ensembl:ENSG00000147133 TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor
HNRNPH1 GeneProduct ensembl:ENSG00000169045 HNRNPH1
CSRP1 GeneProduct ensembl:ENSG00000159176 cysteine and glycine-rich protein 1
GRID1 GeneProduct ensembl:ENSG00000182771
CDON GeneProduct ensembl:ENSG00000064309 cell adhesion molecule-related/down-regulated by oncogenes
MYT1 GeneProduct ensembl:ENSG00000196132 Myelin transcription factor 1
C/EBP GeneProduct ensembl:ENSG00000221869 CCAAT/enhancer binding protein (Cebpd), delta
CAMK2A GeneProduct ensembl:ENSG00000070808
MBP GeneProduct ensembl:ENSG00000197971 myelin basic protein
BCL6 GeneProduct ensembl:ENSG00000113916 B cell leukemia/lymphoma 6
GABRR2 GeneProduct ensembl:ENSG00000111886 gamma-aminobutyric acid (GABA) C receptor, subunit rho 2
CTCF GeneProduct ensembl:ENSG00000102974 CCCTC-binding factor
SP3 GeneProduct ensembl:ENSG00000172845 trans-acting transcription factor 3
PRPF3 GeneProduct ensembl:ENSG00000134748 PRP3 pre-mRNA processing factor 3 homolog (yeast)
E2F1 GeneProduct ensembl:ENSG00000101412 E2F transcription factor 1
AMPA GeneProduct ensembl:ENSG00000155511 Glutamate receptor
REST GeneProduct ensembl:ENSG00000084093 RE1-silencing transcription factor
Silences Mecp2 in non-neuronal tissue
MAG GeneProduct ensembl:ENSG00000105695 myelin-associated glycoprotein
GPRIN1 GeneProduct ensembl:ENSG00000169258 G protein-regulated inducer of neurite outgrowth 1
TET1 GeneProduct ensembl:ENSG00000138336 tet methylcytosine dioxygenase 1
IGF1R GeneProduct ensembl:ENSG00000140443
HNRNPF GeneProduct ensembl:ENSG00000169813 Hnrnpf
heterogeneous nuclear ribonucleoprotein F
YB1 GeneProduct ensembl:ENSG00000065978 data obtained with human cell line and mouse primary tissue
Y box protein 1
CREB1 GeneProduct ensembl:ENSG00000118260
IGF1 GeneProduct ensembl:ENSG00000017427 Glutamate receptor
FOXG1 GeneProduct ensembl:ENSG00000176165 Glutamate receptor
PTEN GeneProduct ensembl:ENSG00000171862
DHX9 GeneProduct ensembl:ENSG00000135829 binding to MECP2 confirmed in mice
FUS GeneProduct ensembl:ENSG00000089280 binding to MECP2 confirmed in mice
HNRNPF GeneProduct ensembl:ENSG00000169813 binding to MECP2 confirmed in mice
also known as hnRNPH+F
TARDBP GeneProduct ensembl:ENSG00000120948 binding to MECP2 confirmed in mice
also known as TDP-43
PSIP1 GeneProduct ensembl:ENSG00000164985 binding to MECP2 confirmed in mice
also known as LEDGF
FUT8 GeneProduct ensembl:ENSG00000033170 fucosyltransferase 8
FGF2 GeneProduct ensembl:ENSG00000138685 fibroblast growth factor 2
GRIN1 GeneProduct ensembl:ENSG00000176884 related to FASD (fetal alcohole spectrum disorder)
NMDA receptor subunit: There are 8 different variants of NR1, produced by alternative splicing of GRIN1
FGF3 GeneProduct ensembl:ENSG00000186895 fibroblast growth factor 3
FGF4 GeneProduct ensembl:ENSG00000075388
FGF5 GeneProduct ensembl:ENSG00000138675
NF1 GeneProduct ensembl:ENSG00000196712 neurofibromatosis 1
DLX5 GeneProduct ensembl:ENSG00000105880 distal-less homeobox 5
controls GABA production
GRIA1 GeneProduct ensembl:ENSG00000155511 effect of MECP2 via LEDGF/PSIP1 influenced change of splice variants proven for mice
Subpart of AMPAR receptor
GRIA3 GeneProduct ensembl:ENSG00000125675 effect of MECP2 via LEDGF/PSIP1 influenced change of splice variants proven for mice
Subpart of AMPAR receptor
GRIA4 GeneProduct ensembl:ENSG00000152578 effect of MECP2 via LEDGF/PSIP1 influenced change of splice variants proven for mice
Subpart of AMPAR receptor

References

  1. Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis. Peruzzi F, Prisco M, Dews M, Salomoni P, Grassilli E, Romano G, et al. Mol Cell Biol. 1999 Oct;19(10):7203–15. PubMed Europe PMC Scholia
  2. Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2. Young JI, Hong EP, Castle JC, Crespo-Barreto J, Bowman AB, Rose MF, et al. Proc Natl Acad Sci U S A. 2005 Dec 6;102(49):17551–8. PubMed Europe PMC Scholia
  3. Identification of cis-regulatory elements for MECP2 expression. Liu J, Francke U. Hum Mol Genet. 2006 Jun 1;15(11):1769–82. PubMed Europe PMC Scholia
  4. MicroRNA in schizophrenia: genetic and expression analysis of miR-130b (22q11). Burmistrova OA, Goltsov AY, Abramova LI, Kaleda VG, Orlova VA, Rogaev EI. Biochemistry (Mosc). 2007 May;72(5):578–82. PubMed Europe PMC Scholia
  5. MeCP2-dependent repression of an imprinted miR-184 released by depolarization. Nomura T, Kimura M, Horii T, Morita S, Soejima H, Kudo S, et al. Hum Mol Genet. 2008 Apr 15;17(8):1192–9. PubMed Europe PMC Scholia
  6. MeCP2, a key contributor to neurological disease, activates and represses transcription. Chahrour M, Jung SY, Shaw C, Zhou X, Wong STC, Qin J, et al. Science. 2008 May 30;320(5880):1224–9. PubMed Europe PMC Scholia
  7. MECP2 genomic structure and function: insights from ENCODE. Singh J, Saxena A, Christodoulou J, Ravine D. Nucleic Acids Res. 2008 Nov;36(19):6035–47. PubMed Europe PMC Scholia
  8. NNZ-2566: a Gly-Pro-Glu analogue with neuroprotective efficacy in a rat model of acute focal stroke. Bickerdike MJ, Thomas GB, Batchelor DC, Sirimanne ES, Leong W, Lin H, et al. J Neurol Sci. 2009 Mar 15;278(1–2):85–90. PubMed Europe PMC Scholia
  9. Ischemic preconditioning regulates expression of microRNAs and a predicted target, MeCP2, in mouse cortex. Lusardi TA, Farr CD, Faulkner CL, Pignataro G, Yang T, Lan J, et al. J Cereb Blood Flow Metab. 2010 Apr;30(4):744–56. PubMed Europe PMC Scholia
  10. Cross talk between microRNA and epigenetic regulation in adult neurogenesis. Szulwach KE, Li X, Smrt RD, Li Y, Luo Y, Lin L, et al. J Cell Biol. 2010 Apr 5;189(1):127–41. PubMed Europe PMC Scholia
  11. Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate. Maezawa I, Jin LW. J Neurosci. 2010 Apr 14;30(15):5346–56. PubMed Europe PMC Scholia
  12. Alternative polyadenylation of MeCP2: Influence of cis-acting elements and trans-acting factors. Newnham CM, Hall-Pogar T, Liang S, Wu J, Tian B, Hu J, et al. RNA Biol. 2010;7(3):361–72. PubMed Europe PMC Scholia
  13. Epigenetic regulation of miR-184 by MBD1 governs neural stem cell proliferation and differentiation. Liu C, Teng ZQ, Santistevan NJ, Szulwach KE, Guo W, Jin P, et al. Cell Stem Cell. 2010 May 7;6(5):433–44. PubMed Europe PMC Scholia
  14. A novel transcriptional regulator of myelin gene expression: implications for neurodevelopmental disorders. Vora P, Mina R, Namaka M, Frost EE. Neuroreport. 2010 Oct 6;21(14):917–21. PubMed Europe PMC Scholia
  15. Disrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome. Urdinguio RG, Fernandez AF, Lopez-Nieva P, Rossi S, Huertas D, Kulis M, et al. Epigenetics. 2010 Oct 1;5(7):656–63. PubMed Europe PMC Scholia
  16. A brain-derived MeCP2 complex supports a role for MeCP2 in RNA processing. Long SW, Ooi JYY, Yau PM, Jones PL. Biosci Rep. 2011 Oct;31(5):333–43. PubMed Europe PMC Scholia
  17. Reduced AKT/mTOR signaling and protein synthesis dysregulation in a Rett syndrome animal model. Ricciardi S, Boggio EM, Grosso S, Lonetti G, Forlani G, Stefanelli G, et al. Hum Mol Genet. 2011 Mar 15;20(6):1182–96. PubMed Europe PMC Scholia
  18. Synaptic signaling and aberrant RNA splicing in autism spectrum disorders. Smith RM, Sadee W. Front Synaptic Neurosci. 2011 Jan 26;3:1. PubMed Europe PMC Scholia
  19. Chronic intermittent ethanol exposure and its removal induce a different miRNA expression pattern in primary cortical neuronal cultures. Guo Y, Chen Y, Carreon S, Qiang M. Alcohol Clin Exp Res. 2012 Jun;36(6):1058–66. PubMed Europe PMC Scholia
  20. Downregulation of CNPase in a MeCP2 deficient mouse model of Rett syndrome. Wu W, Gu W, Xu X, Shang S, Zhao Z. Neurol Res. 2012 Mar;34(2):107–13. PubMed Europe PMC Scholia
  21. Phosphorylation of distinct sites in MeCP2 modifies cofactor associations and the dynamics of transcriptional regulation. Gonzales ML, Adams S, Dunaway KW, LaSalle JM. Mol Cell Biol. 2012 Jul;32(14):2894–903. PubMed Europe PMC Scholia
  22. MeCP2 modulates gene expression pathways in astrocytes. Yasui DH, Xu H, Dunaway KW, Lasalle JM, Jin LW, Maezawa I. Mol Autism. 2013 Jan 25;4(1):3. PubMed Europe PMC Scholia
  23. Human-specific regulation of MeCP2 levels in fetal brains by microRNA miR-483-5p. Han K, Gennarino VA, Lee Y, Pang K, Hashimoto-Torii K, Choufani S, et al. Genes Dev. 2013 Mar 1;27(5):485–90. PubMed Europe PMC Scholia
  24. Dysregulation of the long non-coding RNA transcriptome in a Rett syndrome mouse model. Petazzi P, Sandoval J, Szczesna K, Jorge OC, Roa L, Sayols S, et al. RNA Biol. 2013 Jul;10(7):1197–203. PubMed Europe PMC Scholia
  25. Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR/SMRT co-repressor. Lyst MJ, Ekiert R, Ebert DH, Merusi C, Nowak J, Selfridge J, et al. Nat Neurosci. 2013 Jul;16(7):898–902. PubMed Europe PMC Scholia
  26. MicroRNA-mediated epigenetic silencing of sirtuin1 contributes to impaired angiogenic responses. Volkmann I, Kumarswamy R, Pfaff N, Fiedler J, Dangwal S, Holzmann A, et al. Circ Res. 2013 Sep 27;113(8):997–1003. PubMed Europe PMC Scholia
  27. Identification of TET1 Partners That Control Its DNA-Demethylating Function. Cartron PF, Nadaradjane A, Lepape F, Lalier L, Gardie B, Vallette FM. Genes Cancer. 2013 May;4(5–6):235–41. PubMed Europe PMC Scholia
  28. Rett syndrome and MeCP2. Liyanage VRB, Rastegar M. Neuromolecular Med. 2014 Jun;16(2):231–64. PubMed Europe PMC Scholia
  29. Dysregulation of the IGF-I/PI3K/AKT/mTOR signaling pathway in autism spectrum disorders. Chen J, Alberts I, Li X. Int J Dev Neurosci. 2014 Jun;35:35–41. PubMed Europe PMC Scholia
  30. GluD1 is a common altered player in neuronal differentiation from both MECP2-mutated and CDKL5-mutated iPS cells. Livide G, Patriarchi T, Amenduni M, Amabile S, Yasui D, Calcagno E, et al. Eur J Hum Genet. 2015 Feb;23(2):195–201. PubMed Europe PMC Scholia
  31. Transcriptional regulation of GAD1 GABA synthesis gene in the prefrontal cortex of subjects with schizophrenia. Mitchell AC, Jiang Y, Peter C, Akbarian S. Schizophr Res. 2015 Sep;167(1–3):28–34. PubMed Europe PMC Scholia
  32. Misregulation of Alternative Splicing in a Mouse Model of Rett Syndrome. Li R, Dong Q, Yuan X, Zeng X, Gao Y, Chiao C, et al. PLoS Genet. 2016 Jun 28;12(6):e1006129. PubMed Europe PMC Scholia
  33. Population pharmacokinetics of NNZ-2566 in healthy subjects. Oosterholt SP, Horrigan J, Jones N, Glass L, Della Pasqua O. Eur J Pharm Sci. 2017 Nov 15;109S:S98–107. PubMed Europe PMC Scholia